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'p ~ 0.001, "p ~ 0.007, '''p ~ 0.07 (All comparison made with preceding group)
Edward A. Chasteney, PS. Ravichandran, Deborah Tuke Bahlman, Alan Shearin,
Kenton W. Gregory. Oregon Health Sciences University, Oregon Medical Laser Center,
Department of Veterans Affairs Medical Center; Portland, Oregon
Stenotic Lesions Reliably Form in Porcine
Coronary Arteries Using Copper Stents or
Intracoronary Heating
Prevention of Subacute Stent Thrombosis by
Polymer-Polyethylene Oxide-Heparin Coating in
the Rabbit Carotid Artery
Occlusion 90 min postLT
Global EF 0.49 ± 0.09 0.55 ± 0.04 NS
Index 17± 0.1 1.1 ±01 (p < 0.051
Grafted Region Wall Motion 4 1 (p < 001)
%Wall Thick. -5 31 (p < 0.01)
Inflammation Calcification Neovascular Fibrosis Necrosis
H C H C H C H C H C
Intima 3% 90%:1: 3% 50%; 3% 65%:1: 3% 50%:1: 11% 5%
Media 25% 95%; 22% 5% 11% 63%:1: 8% 74%* 69% 26%*
Adventitia 69% 70% 11% 5% 17% 40%* 64% 55% 11% 5%
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Michael E. Staab, Daniel K. Meeker, William D. Edwards, Sanjay S. Srivatsa, Myung
Ho Jeong, David R. Holmes Jr., Robert S. Schwartz. Mayo Clinic and Foundation,
Rochester, MN
The capability of creating stenotic lesions in an animal model is essential
to testing new interventional devices. We developed a coronary stenosis
model in domestic swine using either heated balloon angioplasty (heat) at
high-temperature (80°C for 15 seconds) or copper stents (copper). Animals
were sacrificed 14-47 days after artery injury. Morphometric and histologic
study of the stenoses created by heat (14 pigs, 33 arteries) and copper (9
pigs, 18 arteries) was performed. Measurement of lumen area and area cir-
cumscribed by the internal elastic lamina (IEL) was used to calculate steno-
sis by l-{lumen/IEL). Mean stenosis from heat was 66.9 ± 27% and copper
80.7 ± 22%. Stenoses exceeding 50% were produced by heat 78.8% and
copper stents 87.5% of the time. Histologically, the heat group was notable
for concentric intimal hyperplasia, intact elastic laminae, necrosis of medial
cells, calcific deposits in the media, and mild adventitial inflammation and fi-
brosis. Copper stent lesions demonstrated severe diffuse inflammation, de-
struction of the elastic laminae, neovascularization, and mild intimal calcifi-
cation around stent tines.
Percent of Arteries with Histologic Feature
Conclusion: Heated balloon angioplasty or deployment of copper stents
into swine coronary arteries reliably creates severe stenoses suitable for test-
ing new interventional devices. Copper stents in particular create very tight
and complicated lesions that would challenge new devices. The histopathol-
ogy differs with copper demonstrating destructive inflammatory lesions vs.
orderly intimal hyperplasia and medial calcification observed in heat lesions.
Conclusions: 1) LT is able to rapidly remove large amounts of thrombus
in CABG. 2) Thrombus removal by LT does not cause detectable changes in
regional cardiac function. 3) High patency rates persist 90 min. post L1.
Fisher's Exact Test, two-sided: 'P::5 0.05,;p::5 0.0001 H ~ Heat C ~ Copper
Sushll Sheth, Vishva Dev, Harvey Jacobs, James S. Forrester, Frank Litvack, Neal
L. Eigler. Cedars-Sinai Medical Center, Los Angeles, CA; University of Utah, Salt Lake
City, UT
Our goals were to develop a rabbit model of subacute stent thrombosis and
to evaluate the efficacy of a polymer stent coating with covalently bound
heparin for its prevention. Bare metal stents (a nitinol wire coil with 3 stain-
less steel joints) were implanted in a carotid artery of 10 NNJ rabbits with a
3.0 mm balloon catheter, inflated twice at 6 atm for 1 minute. Systemic an-
tiplatelet and antithrombotic therapy was withheld. Animals were sacrificed
at 24, 72 and 96 hours. Only the 96 hour group consistently developed occlu-
sive or subocclusive thrombosis. Heparin (0.28 J.l.g/cm2j was linked onto the
surface of soluble polymer chains of segmented polyurethaneurea (SPUU)
or aliphatic Tecoflex polyurethane membrane (50 J.l.m thick). using polyethy-
lene oxide (PEO) as a hydrophilic spacer group. Eight stents were coated
with this polymer-PEO-Heparin coating. Eight bare metal stents and 8 coated
stents were deployed in a carotid artery of 16 NNJ rabbits. All animals were
sacrificed at 96 hours. At the time of sacrifice, both carotids (stented and
contralateral nonstented) were exposed and resting blood flow measured.
The amount of thrombus on each stent was assessed by a semiquantitative
grading scale (I: no lumen encroachment; II: lumen encroachment; III: sub-
occlusive thrombus; IV: occlusive thrombus) and by the weight of the dry
thrombus.
Results:
11001-291
Rapid Thrombolysis in Experimental Coronary
Artery Bypass Grafts
Baseline Post-tPA Post-PTCA
TIMI Thrombus Scale 2.2 ± 1.0 1.6 ± 1.2" 0.5 ± 0.9'
MLD by QCA (mm) 0.82 ± 0.42 0.89 ± 0.57'" 1.90 ± 0.59'
TIMI Grade Flow 2.6 ± 0.8 2.5 ± 1.0 2.9 ± 0.5
UA and C1. Full delivery of tPA and heparin was possible in 47 pts. Activated
clotting time was >300 sec in all pts. PTCA was performed in 48 pts 20 mins
after completion of the infusion. Systemic fibrinogenolysis (fibrinogen pre
408 ± 120 mg/dL, post 398 ± 114) and thrombin activation (no increase in
fibrinopeptide A or fragment 1.2) did not occur but prolonged clot lysis was
evident (D-Dimer pre 196 ± 179 ng/mL. 4 hours post 849 ± 746, P = 0.0001).
Angiographic outcomes were (mean ± SO):
PTCA was successful «50% residual stenosis) in 87% and 6% had a major
bleeding event. In-hospital outcomes were as follows: death 0, myocardial
infarction 4%, abrupt reclosure 11 %, repeat PTCA 11 %, and CABG 6%.
Conclusion: Intralesional tPA with intracoronary heparin causes prolonged
thrombolysis without thrombin activation and reduces the extent of coronary
thrombus in the setting of unstable angina. It is associated with a high PTCA
success rate and favorable in-hospital outcome. Further investigations of this
method of local adjunctive thrombolysis and PTCA are warranted.
Local Dissolution of Intracoronary Thrombus
with Urokinase Using the Dispatch'· Catheter:
Clinical Studies
Joseph F. Mitchel, Daniel B. Fram, Jeffrey A. Hirst, FrancIs J. K,eman,
Charles Primiano, Adel M. Eldin, David D. Waters, Raymond G. McKay. Hartford
Hospital, University of Connecticut Hartford, CT
The Dispatch'· Catheter is a new local drug delivery device which allows
for the prolonged infusion of therapeutic agents at an angioplasty site while
still maintaining distal coronary perfusion. To determine the efficacy of this
device in dissolving intraluminal clot with local urokinase infusion, 29 pa-
tients with thrombus-containing stenoses were treated with the Dispatch'·
catheter either prior to (n = 16) or following (n = 13) coronary angioplasty
or directional atherectomy. The study group consisted of 15 males and 14
females with a mean age of 58.1 years. Clinical diagnoses included unstable
angina (n = 14), acute myocardial infarction (n = 11) or post infarction angina
(n = 4). Urokinase was infused at either 10,000 unitlcc (n = 22) or 30,000
units/cc (n = 7) at 0.5 cclmin for up to 30 minutes. All coronary angiograms
were analyzed to determine Thrombus Score (0--3), TIMI flow, and quanti-
tative coronary measurements pre and post Dispatch'· therapy. (Thrombus
Score: 0 = no thrombus, 1 = possible thrombus, 2 = definite thrombus <3
mm,3 = definite thrombus >3 mm).
Results: Infusions of urokinase for 30 mins were well tolerated in 25 pa-
tients without adverse clinical, hemodynamic or electrical sequelae. In the
remaining 4 patients, limited infusions were tolerated only for 2.5, 5, 6 and
11 mins because of chest pain with EKG changes secondary either to side-
branch occlusion or inadequete distal perfusion. For the entire study group,
Thrombus Score decreased from 2.0 ± 0.7 to 0.5 ± 0.8, TIMI Flow increased
from 2.1 ± 1.3 to 3.0 ± 0.0, and minimal lumen diameter increased from 0.70
± 0.59 to 1.58 ± 0.51 mm (all p < 0.01). Distal embolization, no-reflow, and
abrupt closure were not observed in any patient.
Conclusions: Reduction of thrombus-containing stenoses and dissolution
of intracoronary thrombus can be rapidly achieved in patients with infusions
of limited quantities of urokinase with the Dispatch'· catheter. Sidebranch
occlusion and inability to dilate coronary stenoses with inadequate distal per-
fusion may limit the duration of drug infusion with this device.
CABG thrombosis is a common disorder without adequate therapy. To as-
sess the effects of selective laser thrombolysis (LTlin CABG, aortocoronary
bypasses were created and completely thrombosed in nine swine. Maximal
thrombus removal was achieved with pulsed dye laser light (577 nm, 1 J.l.S
pulse, 3 Hz, 64 mJ/pulse) by fluid catheter for 6.7 ± 1 min. Graft flow and
thrombosis were assessed by angio with global and grafted segment my-
ocardial function measured by epicardial echo at constant load. Mean graft
size: 8 mm x 6 cm. Prior to therapy, grafts had no flow (TIMID) and complete
thrombosis for 60 min. TIM I flow post LTwas 2.8 ± 0.4 (p < 0.001) with focal
residual mural thrombus. 90 min post LT, graft appearance and flow were un-
changed. Wall motion (WM) scored from normal (11 to dyskinetic (4). Index
= total WM/14 segments.
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Three-Dimensional Reconstruction of Atrial
Septal Defect from Intracardlac Ultrasound
Imaging: Dynamic Shape Change of the Defect
in Cardiac Cycle
Kazuyuki Koike, Toshiki Kobayashi, Katsumi Arai, Shunei Kyo, Ryozo Omoto.
Saitama Medical School, Sa/tama, Japan
Currently available transcatheter techniques closing atrial septal defect (ASD)
are only suitable for small to moderate sized ones. Assessment of the shape
and size of ASD as well as their changes in cardiac cycle may be important
when transcatheter closure is applied to larger sized defects.
We have developed a three-dimensional reconstruction (3DR) of ASD from
images obtained with intracardiac ultrasound (ICUS). Preliminary study dis-
closed inadequate image quality of ICUS probes with 15 MHz or higher
transmission frequency for ASD assessment. Newly developed 10 MHz, 6
Fr. reusable rotating probes was used in this study. ICUS images were ob-
tained from 4 patients with secundum ASD; age 2.3 to 12 years (median
6.5). weight 11.5 to 44 kg (median 19). A 7 Fr. guiding long sheath was in-
troduced from the femoral vein and placed in the superior vena cava. A 6 Fr.
ICUS probe was introduced into the long sheath and ECG gated seriallCUS
images were obtained through it. Images were recorded on videotape with
1 mm step manual pullback to the inferior vena cava.
The probe was stable in cardiac cycle and the 3DR was achieved with
high resolution images. En face view of ASD could be obtained from the
both sides of the septum in all patients. Cross-sectional area of the defect
(2.47 ± 0.15 cm2) changed significantly in cardiac cycle (4 to 58% larger in
systole than in diastole). The largest size of the defect in the cardiac cycle
was in endsystole coincided with peak Doppler left to right shunt across
the defect. This dynamic shape change of the ASD may have necessitated
various conventional transcatheter ASD closure devices double in size to the
actua I defect.
We concluded that 3DR of ASD from ICUS images can provide important
information for the development of new transcatheter ASD closure devices.
followup, however, growth rates of right heart structures did not differ for
mild PS versus severe PS and PAtr groups. Ductal flow in utero was ante-
grade in systole in all with mild PS, but was either bidirectional (5 severe PS)
or retrograde only 14 severe PS, all PAtr) in the severe PS and PAtr groups.
Initial RV outflow gradients by Doppler did not differ between the mild and
severe PS groups with antegrade PA flow (mean 26 ± 12 mmHg). Pulmonary
insufficiency was a consistent feature in fetuses with mild PS, but was not
present in the severe PS or PAtr groups. By color Doppler, 3/4 with mild PS
had mild tricuspid regurgitation, whereas mild or moderate tricuspid regur-
gitation was found in 9/9 with severe PS and 4/5 with PAtr. When severe PS
and PAtr groups were compared, there was no significant difference in ini-
tial Z-scores or growth rates of right heart structures between the groups.
Tricuspid regurgitation severity and initial RV pressure by the tricuspid regur-
gitation jet (mean 71 ± 21 mmHg) also did not differ between the severe PS
and PAtr groups. On serial followup in 6/8 with severe RV outflow obstruc-
tion (1 PAtr, 7 severe PS), the RV pressure increased by 18--47 mmHg. In
3/6 serially studied fetuses with antegrade PA flow (2 severe PS, 1 mild PS),
the RV outflow gradient increased later in gestation. There was no change
in the severity of tricuspid or pulmonary regurgitation during followup in any
fetus. The severity of PS may be differentiated in utero by the direction of
ductal flow, the presence of pulmonary insufficiency, severity of tricuspid in-
sufficiency and the size of the pulmonary valve and PAs. In the absence of
antegrade PA flow, severe PS may be difficult to distinguish from PAtr ante-
natally.
Management of tetralogy of Fallot (TOF) is influenced by the size and
position of the ventricular septal defects (VSD) and the size and magni-
tude of infundibular, and pulmonary annular and arterial obwtruction. Three-
dimensional (3DI visualization may provide valuable information on these
complex lesions and relations to guide gatheter and surgical interventions
in TOF. To assess this, we performed 3D Echo (3DE) in 33 neonates and in-
fants with TOF. In 8 pts additional post-operative studies were acquired. Us-
ing 5 or 7.5 MHz transducers placed within a rotational or fan-like scanning
device positioned on the chest wall or subcostal position, 2DE images were
obtained every two degrees over a span of 180 or 90 degrees with ECG and
Utility of Unique Projections in Dynamic
Transthoracic Three-Dimensional
Echocardlography in the Pre- and
Post-Operative Delineation of Lesions
Associated with Tetralogy of Fallot In Neonates
and Infants
Gerald Marx, Michael Vogel. Achi Ludomirski, Lissa Sugeng, Oi-Ling Cao,
Alain Delabays, Barbara Romero, David FUlton, Natesa Pandian. Tufts-New England
Medical Center, Boston, MA; Brompton Hospital, London, England; Univ of Michigan,
Ann Arbor, Michigan
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Comparison of Different Vasodilators on
Coronary Flow Reserve In Patients with
Documented Coronary Artery Disease
Mun K. Hong, Augusto D. Pichard, 5, Chiu Wong, Kenneth M. Kent, Lowell
F. Satler. Gaston R. Dussaillant, Ya Chien Chuang, Julie L. MacKenzie, Martin
B. Leon, Washington Hospital Center, Washington, DC
Bare Stent (N = 8)
Heparin Stent {N = 81
p-value
No-reflow phenomenon after angioplasty or atherectomy may result in im-
portant ischemic complications. No-reflow phenomenon is related to distal
embolization of microparticulate material andlor spasm in the microcircula-
tion. Maximal vasodilatation of the coronary microcirculation may prevent or
terminate episodes of no-reflow phenomenon, In this preliminary study, we
evaluated the vasodilatory capacities of agents commonly used during coro-
nary procedures, The coronary flow reserve (CFR = hyperemiclbasal flow ve-
locity) was measured with 0.018" Doppler FloWire in coronary arteries with
<50% diameter stenoses (6 RCA. 4 LAD, and 10 LCX) in 20 patients (mean
age = 64 ± 7 years; 15 men) undergoing angiography (n = 6) or angioplasty
(n = 14) in another coronary artery. Random paired CFR measurements in
the same artery were obtained with intracoronary adenosine. nitroglycerin
(NTG), verapamil, and contrast agents (Hypaque, Hexabrix, and Optiray). with
blood injection as a control. After each measurement, basal flow conditions
were restored before subsequent test injections. At the doses chosen, there
were no hemodynamic or conduction abnormalities, which could influence
coronary flow responses.
Conclusions: The 96 hour rabbit carotid model yields a high frequency of
occlusive and subocclusive subacute thrombosis. The stents coated with
polymer-PEa-Heparin accumulate significantly less thrombus and have bet-
ter patency than the uncoated stents at 96 hours in this model of subacute
stent thrombosis.
In Utero Pulmonary Outflow Obstruction: Natural
History and Predictors of Postnatal Severity
Ltsa K. Hornberger, Philip J, Spevak. Robert W. McDonald, Mary J. Rice, Gerard
R. Martin, Stephen P. Sanders, Steven D. Colan, David J. Sahn. Children's Hospital,
Boston, MA; Oregon Health Sci Univ, Portland, OR; Children's National Medical Center,
Washington, DC
We reviewed prenatal and postnatal echocardiograms of fetuses with pul-
monary stenosis (PS. n = 14) and pulmonary atresia (PAtr. n = 5), to elucidate
the antenatal natural history of PS and PAtr and identify predictors of severe
postnatal disease. Fifteen were serially studied in utero (age at first study
24 ± 4wks). Fetuses with PS were divided into severe and mild groups ac-
cording to whether they were (9) or were not (4) ductus-dependent at birth,
respectively. Measurements of RV short and long-axis, tricuspid valve, main
and branch pulmonary artery (PA) and pulmonary valve dimensions were con-
verted to Z-scores based on age-adjusted normal fetal data. At the initial
exam, main and branch PA and pulmonary valve Z-scores were larger in fe-
tuses with mild PS than in those with severe PS or PAtr (p :s 0.01). On serial
Among different contrast agents, there was no difference in CFR, although
duration of hyperemia was significantly longer with Hypaque vs. other con-
trast agents (p < 0.001 by ANOVA). We conclude that adenosine and Hy-
paque had the highest vasodilatory effect among the agents tested. These
agents should be further studied for a potential benefit in the prevention
or treatment of no-reflow phenomenon during angioplasty and atherectomy
procedures.
CFR* 2.2 ± 0.9** 14 ± 0.3 1.5 ± 03 1.7 ± 0.4 1.8 ± 0.5 2.1± 0.8 1.2 ± 0 1
Duration* 29 ± 9*** 58 ± 63 77 ± 57 21 ± 7 22 ± 9 35 ± 10 9 ± 5
*p < 0.001 by ANOVA and multiple pairwise comparisons with Bonferroni correction,
using adenosine as the comparison group, up < 0,001 vs. all others except Hypaque,
***p < 0.05 vs. all others except verapamil (100 ILg) and Hypaque: Duration of hyperemic
response in seconds
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